Bicara Therapeutics Inc. BCAX
Set alert
8.99 USD +1.06 +13.40%
As of Nov 3, 10:17 AM ET
7.90 Day range 9.00
7.87 52-week range 30.99
- YTD
- -46.57%
- 1 year
- -43.72%
- Open
- 8.03
- Prev close
- 7.93
- Mkt cap
- 595.56M
- Vol
- 290.53K
- Avg vol
- 1.06M
- EPS
- -3.08
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 7.90
- High
- 9.00
- Forward P/E
- -4.96
- Beta
- -0.69
- Short ratio
- 16.85
- Inst. own
- 102.47%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 9, 2026
- 50-d avg
- 20.82
- 200-d avg
- 21.33
- 1y target
- 35.67
5D chart
Signals (93)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Nov 3, 9:50 AM | 27 minutes ago |
| RSI: Overbought | Nov 3, 9:35 AM | 42 minutes ago |
| SMA: Bullish | Nov 3, 9:30 AM | 47 minutes ago |
| SMA: Bullish | Nov 3, 9:30 AM | 47 minutes ago |
| MACD: Buy Signal | Nov 3, 9:30 AM | 47 minutes ago |
| RSI: Oversold | Nov 2, 3:50 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 3:35 PM | 18 hours ago |
| RSI: Oversold | Nov 2, 3:30 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 3:10 PM | 19 hours ago |
| MACD: Buy Signal | Nov 2, 2:40 PM | 19 hours ago |
| RSI: Oversold | Nov 2, 2:35 PM | 19 hours ago |
| RSI: Oversold | Nov 2, 2:15 PM | 20 hours ago |
| RSI: Oversold | Nov 2, 1:40 PM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 1:30 PM | 20 hours ago |
| SMA: Bearish | Nov 2, 1:15 PM | 21 hours ago |
| SMA: Bearish | Nov 2, 1:10 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:05 PM | 21 hours ago |
| SMA: Bullish | Nov 2, 1:00 PM | 21 hours ago |
| MACD: Buy Signal | Nov 2, 11:50 AM | 22 hours ago |
| SMA: Bearish | Nov 2, 10:55 AM | 23 hours ago |
Newest 20 of 93.
Financial health
Altman Z-Score
5.84 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C+2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 5
- P/E 1
- P/B 2
Valuation
P/E -6.7×
FY 2022 5y median -18.7× FY 2025
P/S 0.0×
FY 2022 5y median 0.0× FY 2025
P/B 2.3×
FY 2022 5y median 2.1× FY 2025
P/FCF -8.6×
FY 2022 5y median -19.4× FY 2025
EV/EBITDA -6.0×
FY 2022 5y median -12.8× FY 2025
EV/Sales 0.0×
FY 2022 5y median 0.0× FY 2025
FCF Yield -11.6%
FY 2022 5y median -5.9% FY 2025
Profitability
Gross Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2022 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2022 5y median 0.0% FY 2025
ROE -34.4%
FY 2022 5y median -18.8% FY 2025
ROIC -38.6%
FY 2022 5y median -16.6% FY 2025
ROA -32.0%
FY 2022 5y median -27.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2022 FY 2025
Operating Income -88.9%
FY 2022 FY 2025
EPS (diluted) -101.6%
FY 2022 FY 2025
Free Cash Flow -43.2%
FY 2022 FY 2025
Financial Health
Current Ratio 14.6×
FY 2022 5y median 14.9× FY 2025
Quick Ratio 14.6×
FY 2022 5y median 14.9× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2022 5y median 2.6× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31